Company filings profile · CIK 0001514183
Silo Pharma, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Silo Pharma, Inc. (SILO): 13 filings in the last 90 days vs 5 in the prior 90 (filing-velocity rising ↑ · 2.6×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — Silo Pharma, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 18, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jun 3, 2026 | Item 3.03; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 1, 2026 | Other Events | ↗ |
| Apr 2, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Feb 23, 2026 | Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Dec 29, 2025 | Delisting / Listing-Rule Failure | ↗ |
| Oct 24, 2025 | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| Oct 1, 2025 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 5, 2025 | Other Events; Financial Statements and Exhibits | ↗ |
Watch Silo Pharma, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 18, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | PRE 14A | DEFINITIVE PROXY STATEMENT | ↗ |
| Jun 3, 2026 | 8-K | Item 3.03; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 1, 2026 | 8-K | Other Events | ↗ |
| May 14, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| Apr 16, 2026 | 424B3 | PROSPECTUS | ↗ |
| Apr 15, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Apr 14, 2026 | 424B3 | PROSPECTUS | ↗ |
| Apr 14, 2026 | POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | ↗ |
| Apr 13, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Apr 10, 2026 | POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 | ↗ |
| Apr 2, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Mar 27, 2026 | 10-K | ANNUAL REPORT | ↗ |
| Feb 23, 2026 | 8-K | Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Dec 29, 2025 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Dec 16, 2025 | 4 | ↗ | |
| Nov 26, 2025 | EFFECT | Item ; Item ; Item | ↗ |
| Nov 26, 2025 | 424B3 | PROSPECTUS | ↗ |
| Nov 24, 2025 | CORRESP | ↗ | |
| Nov 21, 2025 | 4 | ↗ | |
| Nov 20, 2025 | 4 | ↗ | |
| Nov 14, 2025 | SCHEDULE 13G | ↗ | |
| Nov 13, 2025 | 10-Q | QUARTERLY REPORT | ↗ |
| Nov 7, 2025 | SCHEDULE 13G/A | ↗ | |
| Oct 29, 2025 | S-1 | REGISTRATION STATEMENT | ↗ |
| Oct 24, 2025 | 8-K | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| Oct 3, 2025 | SCHEDULE 13G | ↗ | |
| Oct 1, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Oct 1, 2025 | 424B5 | PROSPECTUS SUPPLEMENT | ↗ |
| Sep 5, 2025 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ↗ |
| Sep 5, 2025 | ARS | ARS | ↗ |
| Sep 5, 2025 | DEF 14A | DEFINITIVE PROXY STATEMENT | ↗ |
| Aug 25, 2025 | PRE 14A | PRELIMINARY PROXY STATEMENT | ↗ |
| Aug 18, 2025 | 424B5 | PROSPECTUS SUPPLEMENT | ↗ |
| Aug 13, 2025 | 10-Q | QUARTERLY REPORT | ↗ |
| Aug 12, 2025 | SCHEDULE 13G/A | ↗ | |
| Aug 5, 2025 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |